肾移植受者移植后糖尿病预后影响的荟萃分析
结果显示PTDM显著增加全因死亡、心血管死亡、脓毒症相关死亡及移植物衰竭风险,但与恶性肿瘤相关死亡无显著关联。
要点
- PTDM与全因死亡风险增加70%相关(RR 1.70)。
- PTDM与心血管死亡风险增加86%相关(RR 1.86)。
- PTDM与移植物衰竭风险增加33%相关(RR 1.33)。
核心结论
- PTDM与肾移植受者全因死亡、心血管死亡、脓毒症相关死亡及移植物衰竭风险显著增加相关。
- PTDM与恶性肿瘤相关死亡无显著关联。
研究设计与样本
- 系统检索PubMed、Ovid/Medline、Web of Science、Scopus和Cochrane Library数据库。
主要发现
- 恶性肿瘤相关死亡RR 1.20,95%CI 0.76-1.88,无显著关联。
临床怎么用
- 应重视肾移植受者PTDM的综合管理以改善预后。
- 需针对PTDM开展进一步研究以优化移植受者结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Post-transplant diabetes mellitus (PTDM) is a complex condition arising from various factors including immunosuppressive medications, insulin resistance, impaired insulin secretion and inflammatory processes. Its impact on patient and graft survival is a significant concern in kidney transplant recipients. PTDM's impact on kidney transplant recipients, including patient and graft survival and cardiovascular mortality, is a significant concern, given conflicting findings in previous studies. This meta-analysis was imperative not only to incorporate emerging evidence but also to delve into cause-specific mortality considerations. We aimed to comprehensively evaluate the association between PTDM and clinical outcomes, including all-cause and cardiovascular mortality, sepsis-related mortality, malignancy-related mortality and graft loss, in kidney transplant recipients. METHODS: PubMed, Ovid/Medline, Web of Science, Scopus and Cochrane Library databases were screened and studies evaluating the effect of PTDM on all-cause mortality, cardiovascular mortality, sepsis-related mortality, malignancy-related mortality and overall graft loss in adult kidney transplant recipients were included. RESULTS: Fifty-three studies, encompassing a total of 138 917 patients, evaluating the association between PTDM and clinical outcomes were included. Our analysis revealed a significant increase in all-cause mortality [risk ratio (RR) 1.70, 95% confidence interval (CI) 1.53 to 1.89, P < .001] and cardiovascular mortality (RR 1.86, 95% CI 1.36 to 2.54, P < .001) among individuals with PTDM. Moreover, PTDM was associated with a higher risk of sepsis-related mortality (RR 1.96, 95% CI 1.51 to 2.54, P < .001) but showed no significant association with malignancy-related mortality (RR 1.20, 95% CI 0.76 to 1.88). Additionally, PTDM was linked to an increased risk of overall graft failure (RR 1.33, 95% CI 1.16 to 1.54, P < .001). CONCLUSION: These findings underscore the importance of comprehensive management strategies and the need for research targeting PTDM to improve outcomes in kidney transplant recipients.
引用
- Kanbay M, Siriopol D, Guldan M, et al. Prognostic impact of post-transplant diabetes mellitus in kidney allograft recipients: a meta-analysis. Nephrol Dial Transplant. 2025. PMID: 39134508. doi:10.1093/ndt/gfae185
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。